NEXL Message Board - Msg: 13142664

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NEXL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rick Costantino who wrote ()	3/9/2000 4:40:00 PM
From: eadvantage	of 1704

More Great News! "IRVINE, Calif.--(BW HealthWire)--March 9, 2000--Nexell Therapeutics Inc. (NASDAQ:NEXL), one of the world's leading suppliers of therapeutic and diagnostic products based on stem cell technology,announced today that it will introduce a new reagent kit that will allow researchers to produce enriched quantities of monocytes, a type of white blood cell that can be readily manipulated to produce dendritic cells for research. Dendritic cells are being used by many clinical investigators to produce novel experimental cancer vaccines."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next